News>
Tempest Therapeutics special meeting adjourned after proposal fell short of required votes
- Tempest Therapeutics held a reconvened special shareholder meeting on Aug. 17, 2026.
- Shareholders did not adopt a charter amendment to replace certain supermajority voting requirements.
- Shareholders also did not authorize a charter change to permit shareholder action by written consent.
- The meeting was adjourned to Sept. 15, 2026 to seek additional votes on the same charter amendment.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempest Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-355550), on August 18, 2026, and is solely responsible for the information contained therein.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Trade now！
You may also like
Crypto prices
More
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now